CytoDyn Inc (CYDY)
0.146
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
CytoDyn Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| November 30, 2021 | -3.462 |
| Date | Value |
|---|---|
| August 31, 2021 | -2.038 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.462
Minimum
Nov 2021
-2.038
Maximum
Aug 2021
-2.750
Average
-2.750
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.27M |
| Total Liabilities (Quarterly) | 129.65M |
| Shareholders Equity (Quarterly) | -119.38M |